Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132358) titled 'A Clinical Study on the Efficacy and Safety of Luspatercept Monotherapy for Cancer-Related Anemia (Single-Arm, Multicenter)' on Sept. 14.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
malignancy (including but not limited to hematologic malignancies, lung cancer, gastric cancer, colorectal cancer, breast cancer, pancreatic cancer, etc.) and developed anemia after receiving anti-tumor therapy (including but not limited to targeted therapy, immunotherapy, chemotherapy, etc.).
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrol...